JPRN-jRCT2080222514未知3 期
A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal Dialysis
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)Patients on Peritoneal Dialysis
- •(2)It can be confirmed that the treatment of pruritus with existing therapies such as antihistamines or antiallergics has not been adequately effective in such patients
排除标准
- 未提供
研究者
相似试验
未知
1 期
Clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222359Kowa Co., Ltd.32
未知
1 期
Pharmacokinetic study of TRK-820 -Pharmacokinetic study among TRK-820 tablets and TRK-820 soft capsules.Healthy Japanese MaleJPRN-jRCT1080221878Toray Industries,Inc.8
未知
1 期
clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222360Kowa Co., Ltd.24
未知
1 期
A phase I clinical pharmacology study of TAK-233 in healthy subjectsHealthy adult female subjectsJPRN-jRCT2080222396TAKEDA PHARMACEUTICAL COMPANY LTD.24
进行中（未招募）
1 期
A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive TumorsEUCTR2015-003582-28-ESoxo Oncology Inc151